SEC Comment Letter 0000000000-24-007160 to STANDARD BIOTOOLS INC. (LAB) (CIK 0001162194) (LAB)
STANDARD BIOTOOLS INC. (LAB) (CIK 0001162194)
Date: June 25, 2024 · CIK: 0001162194 · Accession: 0000000000-24-007160
AI Filing Summary & Sentiment
File numbers found in text: 333-280321
Letter
United States securities and exchange commission logo June 25, 2024 Michael Egholm President and Chief Executive Officer Standard BioTools Inc. 2 Tower Place, Ste 2000 South San Francisco, CA 94080 Re:Standard BioTools Inc. Registration Statement on Form S-3 Filed June 20, 2024 File No. 333-280321 Dear Michael Egholm: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Nicholas O'Leary at 202-551-4451 with any questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services cc: John T. Rudy, Esq.
Show Raw Text
United States securities and exchange commission logo
June 25, 2024
Michael Egholm
President and Chief Executive Officer
Standard BioTools Inc.
2 Tower Place, Ste 2000
South San Francisco, CA 94080
Re:Standard BioTools Inc.
Registration Statement on Form S-3
Filed June 20, 2024
File No. 333-280321
Dear Michael Egholm:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Nicholas O'Leary at 202-551-4451 with any questions.
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and
Services
cc: John T. Rudy, Esq.